WPD Pharmaceuticals Inc. is a Canada-based company. The Company is currently not carrying on any active business. It is focused on evaluating opportunities to acquire an interest in an operating business. The Company does not generate revenue.

Employees

Sector

Investment Holding Companies

More about the company

Market Cap	557K 397K 347K 321K 294K 38.21M 566K 3.82M 1.5M 18.66M 1.49M 1.46M 64.42M	P/E 2022	1.32x	P/E 2023	-63.7x
Enterprise Value	775K 552K 482K 446K 409K 53.18M 788K 5.32M 2.09M 25.97M 2.07M 2.03M 89.65M	EV / Sales 2022	-	EV / Sales 2023	-
Free-Float	66.45%	Yield 2022 *	-	Yield 2023	-

25-04-17	Mabion Signs About 2 Mln Zloty Deal With WPD Pharmaceuticals	RE
24-12-12	WPD Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
24-08-29	WPD Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
24-05-28	WPD Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-05-07	WPD Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-05-06	WPD Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt	CI
24-02-05	WPD Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
24-02-02	WPD Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
24-01-30	WPD Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
24-01-25	WPD Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt	CI
23-06-14	WPD Pharmaceuticals Inc. announced that it has received CAD 0.3 million in funding	CI
23-05-01	WPD Pharmaceuticals Inc. Provides Update on Research Project Pipeline	CI
23-05-01	WPD Pharmaceuticals Inc. Announces Directorate Appointments	CI

25-05-08	Canadian Investment Regulatory Organization Trading Halt - WBIO	AQ
24-12-20	CSE Bulletin: Reinstatement - WPD Pharmaceuticals Inc. (WBIO)	NE
24-12-20	Canadian Investment Regulatory Organization Trade Resumption - WBIO	AQ
24-12-06	Canadian Investment Regulatory Organization Trading Halt - WBIO	AQ
24-12-05	WPD Pharmaceuticals : PROPOSED SHARE CONSOLIDATION OF WPD’S COMMON SHARES	PU

Manager	Title	Age	Since
Mariusz Olejniczak CEO	Chief Executive Officer	51	-
Beata Pajak CTO	Chief Tech/Sci/R&D Officer	-	-
Katarzyna Suchoszek COO	Chief Operating Officer	-	-

Director	Title	Age	Since
Peter Novak BRD	Director/Board Member	68	2020-01-07
Teresa Rzepczyk BRD	Director/Board Member	51	2019-04-22
Romuald Harwas BRD	Director/Board Member	54	2022-02-01

WPD Pharmaceuticals Inc. Stock OTC Markets

Stocks

WPDPF

CA92941F2044

Investment Holding Companies

Valuation: WPD Pharmaceuticals Inc.

Latest news : WPD Pharmaceuticals Inc.

Press Releases: WPD Pharmaceuticals Inc.

Quotes and Performance

Managers and Directors: WPD Pharmaceuticals Inc.

Shell Companies

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WPD PHARMACEUTICALS INC.	+99,900.00%	-.--%	-	-	231K
CHURCHILL CAPITAL CORP XI	-5.65%	-8.56%	-	-	877M
EINRIDE AB	-7.74%	-28.12%	-	-	762M
PRIME BEING CORP.	0.00%	0.00%	+44.74%	+391.07%	797M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	0.00%	-0.20%	-	-	642M
DEEP FISSION, INC.	-12.66%	-4.26%	-	-	734M
CHURCHILL CAPITAL CORP XII	0.00%	0.00%	-	-	611M
CANTOR EQUITY PARTNERS IV, INC.	-0.11%	+0.29%	-	-	597M
BAIN CAPITAL GSS INVESTMENT CORP.	+0.20%	-0.10%	-	-	596M
Average	+11,097.12%	-2.63%	+44.74%	+391.07%	701.87M
Weighted average by Cap.	+0.54%	-2.83%	+44.74%	+391.07%

	2022	2023
Net sales	-	-
Net income	3.86M 2.75M 2.4M 2.22M 2.04M 265M 3.92M 26.49M 10.41M 129M 10.32M 10.09M 446M	-80.08K -57.04K -49.86K -46.11K -42.31K -5.5M -81.47K -550K -216K -2.68M -214K -210K -9.27M
Net Debt	-23.79K -16.95K -14.81K -13.7K -12.57K -1.63M -24.21K -163K -64.19K -798K -63.65K -62.25K -2.75M	218K 155K 136K 126K 115K 14.97M 222K 1.5M 588K 7.31M 583K 570K 25.23M